Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-07
DOI
10.1186/s13046-021-01961-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals
- (2020) Saiyang Li et al. Cell Death & Disease
- Can We Translate Non-inferiority Clinical Trial into Practice? Real World Outcome of Sunitinib and Pazopanib as First Line Targeted Therapy in Metastatic Renal Cell Carcinoma: UK Centre Experience
- (2020) S. Bandyopadhyay et al. CLINICAL ONCOLOGY
- Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside
- (2020) Antonio G. Solimando et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial.
- (2020) Miriam Ficial et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
- (2020) Antonella Argentiero et al. Journal of Clinical Medicine
- Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
- (2020) Won Suk Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
- (2020) Laurenz Nagl et al. Frontiers in Cell and Developmental Biology
- Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical Biomarkers
- (2020) Dominik A. Barth et al. Frontiers in Cell and Developmental Biology
- Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
- (2020) Antonio Giovanni Solimando et al. Cancers
- Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
- (2019) David Cella et al. LANCET ONCOLOGY
- Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear cell Renal Cell Cancer - Data from a Randomized Phase III Trial
- (2019) A. Ari Hakimi et al. Cancer Discovery
- Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma
- (2019) Svenja Bihr et al. NEOPLASIA
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
- (2019) Nieves Martínez Chanzá et al. LANCET ONCOLOGY
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) Bernard Escudier et al. ANNALS OF ONCOLOGY
- A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma
- (2019) Martin H. Voss et al. CANCER
- First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics and Anti-Tumor Activity
- (2019) Hui K Gan et al. CLINICAL CANCER RESEARCH
- Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC): Outcomes in the combined IMDC intermediate/poor risk and sarcomatoid subgroups of the phase 3 KEYNOTE-426 study.
- (2019) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor
- (2019) Veronica Mollica et al. Cancers
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models
- (2019) Huizhong Li et al. JOURNAL OF IMMUNOTHERAPY
- The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions
- (2019) Peio Errarte et al. Journal of Advanced Research
- Tumor angiogenesis: causes, consequences, challenges and opportunities
- (2019) Roberta Lugano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells
- (2018) Nicole Kiweler et al. ARCHIVES OF TOXICOLOGY
- Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells
- (2018) Mamta Singla et al. Cancer Cell International
- Current and Emerging Therapies for First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma
- (2018) Michael B. Atkins et al. CANCER TREATMENT REVIEWS
- Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy
- (2018) Xiaolei Li et al. Cellular & Molecular Immunology
- PTEN in kidney cancer: A review and meta-analysis
- (2018) Wan-cai Que et al. CLINICA CHIMICA ACTA
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Cell Carcinoma in von Hippel–Lindau Disease—From Tumor Genetics to Novel Therapeutic Strategies
- (2018) Emily Kim et al. Frontiers in Pediatrics
- Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel–Lindau-Deficient Renal Cancer
- (2018) Florinda Meléndez-Rodríguez et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- THE ROLE OF ENDOTHELIAL COLONY FORMING CELLS IN KIDNEY CANCER’S PATHOGENESIS, AND IN RESISTANCE TO ANTI-VEGFR AGENTS AND mTOR INHIBITORS: A SPECULATIVE REVIEW
- (2018) Valentina Poletto et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Current and Evolving Landscape of First‐Line Treatments for Advanced Renal Cell Carcinoma
- (2018) Emiliano Calvo et al. ONCOLOGIST
- SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)
- (2018) Margitta Retz et al. EUROPEAN JOURNAL OF CANCER
- Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
- (2018) Nuzhat Ahmed et al. SEMINARS IN CANCER BIOLOGY
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
- (2017) Nicholas A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
- (2017) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
- (2017) Hans J. Hammers et al. JOURNAL OF CLINICAL ONCOLOGY
- New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
- (2017) Kevin Zarrabi et al. Journal of Hematology & Oncology
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
- (2017) Rajasekharan Somasundaram et al. Nature Communications
- Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
- (2017) Francisca Dias et al. Oncotarget
- Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway
- (2017) Q Chen et al. Oncogenesis
- The Expression of Fibroblast Activation Protein in Clear Cell Renal Cell Carcinomas Is Associated with Synchronous Lymph Node Metastases
- (2017) Peio Errarte et al. PLoS One
- Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
- (2016) Caroline Razafinjatovo et al. BMC CANCER
- Recent developments in second and third line therapy of metastatic renal cell carcinoma
- (2016) Maria Giuseppa Vitale et al. Expert Review of Anticancer Therapy
- A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review
- (2016) Meta H. M. Diekstra et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion
- (2016) T.Y. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Independent assessment of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma
- (2016) Robert J Motzer et al. LANCET ONCOLOGY
- Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
- (2016) Toni K Choueiri et al. LANCET ONCOLOGY
- Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma
- (2016) Tram Anh Tran et al. MOLECULAR AND CELLULAR BIOLOGY
- IL-8 induces the epithelial-mesenchymal transition of renal cell carcinoma cells through the activation of AKT signaling
- (2016) Nan Zhou et al. Oncology Letters
- Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis
- (2016) Désirée Schönenberger et al. Oncotarget
- VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma
- (2016) Caroline Fanja Razafinjatovo et al. Oncotarget
- miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B
- (2016) Cheng Wang et al. Oncotarget
- Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling
- (2016) Zhao Yang et al. Oncotarget
- Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups
- (2016) G. de Velasco et al. Cancer Immunology Research
- Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma
- (2016) Hana Mlcochova et al. Scientific Reports
- CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma
- (2015) Meta H.M. Diekstra et al. EUROPEAN UROLOGY
- The Role of Hypoxia-Induced miR-210 in Cancer Progression
- (2015) Kyvan Dang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Oxidative Stress Leads to Malignant Transformation Along With Acquisition of Stem Cell Characteristics, and Epithelial to Mesenchymal Transition in Human Renal Epithelial Cells
- (2015) Prathap Kumar S. Mahalingaiah et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sunitinib, Pazopanib or Sorafenib for the Treatment of Patients with Late Relapsing Metastatic Renal Cell Carcinoma
- (2015) Matteo Santoni et al. JOURNAL OF UROLOGY
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer
- (2015) Chantel Samardzija et al. Molecular Cancer
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
- (2015) Sara M. Tolaney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
- (2015) Nathaniel Weygant et al. Oncotarget
- Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
- (2015) Rikke B. Holmgaard et al. Cell Reports
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- Targeting hypoxia at the forefront of anticancer immune responses
- (2015) Muhammad Zaeem Noman et al. OncoImmunology
- Epithelial-to-Mesenchymal Transition in Renal Neoplasms
- (2014) Huiying He et al. ADVANCES IN ANATOMIC PATHOLOGY
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
- (2014) I. B. Barsoum et al. CANCER RESEARCH
- International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia
- (2014) Brett Delahunt et al. EUROPEAN UROLOGY
- Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment
- (2014) Vinit Kumar et al. IMMUNOLOGY
- Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study
- (2014) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Genetics of Clear-Cell Renal Cell Carcinoma
- (2014) James Brugarolas JOURNAL OF CLINICAL ONCOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma
- (2014) Xiaoen Wang et al. Translational Oncology
- Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies
- (2014) Anita Geevarghese et al. Translational Research
- Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
- (2013) B Beuselinck et al. BRITISH JOURNAL OF CANCER
- Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
- (2013) James H. Finke et al. CANCER JOURNAL
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
- (2013) Cora N. Sternberg et al. EUROPEAN JOURNAL OF CANCER
- Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma
- (2013) HIDETO IWAMOTO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma
- (2013) Hirofumi Yoshino et al. JOURNAL OF HUMAN GENETICS
- Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
- (2013) Thomas E Hutson et al. LANCET ONCOLOGY
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment
- (2013) Miyako Kondoh et al. PLoS One
- Targeting Angiogenesis and the Tumor Microenvironment
- (2013) Jennifer Samples et al. Surgical Oncology Clinics of North America
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Heterogeneity of Tumor Endothelial Cells
- (2012) Noritaka Ohga et al. AMERICAN JOURNAL OF PATHOLOGY
- c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma
- (2012) G. T. Gibney et al. ANNALS OF ONCOLOGY
- Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy
- (2012) Ken-ichi Harada et al. BJU INTERNATIONAL
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
- (2012) An Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Cancer-associated fibroblasts as targets for immunotherapy
- (2012) Sunitha Kakarla et al. Immunotherapy
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
- (2012) Martina Redova et al. Journal of Translational Medicine
- TNF- Induces Epithelial-Mesenchymal Transition of Renal Cell Carcinoma Cells via a GSK3 -Dependent Mechanism
- (2012) M.-Y. Ho et al. MOLECULAR CANCER RESEARCH
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The VHL/HIF axis in clear cell renal carcinoma
- (2012) Chuan Shen et al. SEMINARS IN CANCER BIOLOGY
- Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents
- (2011) Norman H. Lee Anti-Cancer Agents in Medicinal Chemistry
- Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
- (2011) M. Hong et al. CANCER RESEARCH
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
- (2011) K. J. Gotink et al. CLINICAL CANCER RESEARCH
- Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth
- (2011) H. Huang et al. CLINICAL CANCER RESEARCH
- Tumor exploits alternative strategies to achieve vascularization
- (2011) Benedetta Bussolati et al. FASEB JOURNAL
- Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition
- (2011) Anna-Karin Boström et al. HUMAN PATHOLOGY
- Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells
- (2011) Chikara Muraki et al. INTERNATIONAL JOURNAL OF CANCER
- Sunitinib-induced changes in circulating endothelial cell-related proteins in patients with metastatic renal cell cancer
- (2011) Astrid A.M. van der Veldt et al. INTERNATIONAL JOURNAL OF CANCER
- WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia
- (2011) Gregory McCarty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition
- (2011) J. L. Conant et al. JOURNAL OF CLINICAL PATHOLOGY
- Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts
- (2011) Veronique Lorgis et al. JOURNAL OF NEURO-ONCOLOGY
- Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis
- (2011) Shuji Mikami et al. LABORATORY INVESTIGATION
- Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma
- (2011) Ilya Tsimafeyeu et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
- (2010) Sascha Seidel et al. BRAIN
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor heterogeneity: Causes and consequences
- (2009) Andriy Marusyk et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Human Renal Cancer Cells Express a Novel Membrane-Bound Interleukin-15 that Induces, in Response to the Soluble Interleukin-15 Receptor α Chain, Epithelial-to-Mesenchymal Transition
- (2009) Krystel Khawam et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
- (2009) Y.-Q. Xiong et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Glioma-associated endothelial cells are chemoresistant to temozolomide
- (2009) Jenilyn J. Virrey et al. JOURNAL OF NEURO-ONCOLOGY
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- HIF-2 maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells
- (2009) A. Pietras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Stem Cells, Hypoxia and Metastasis
- (2009) Richard P. Hill et al. SEMINARS IN RADIATION ONCOLOGY
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal Carcinoma
- (2008) John D. Gordan et al. CANCER CELL
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Identification of a tumor-initiating stem cell population in human renal carcinomas
- (2008) Benedetta Bussolati et al. FASEB JOURNAL
- CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
- (2008) Daniel Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin
- (2008) Domenica Mangieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Endothelial cell differentiation of human breast tumour stem/progenitor cells
- (2008) Benedetta Bussolati et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
- (2008) N. Dumont et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
- (2008) Bikul Das et al. STEM CELLS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started